RMD News: Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis - 18th Jun 2024, 10:58pm

[annb0t]

Quest Diagnostics DGX recently completed the acquisition of the PathAI Diagnostics business from PathAI, the global provider of artificial intelligence (AI)-powered technology for pathology. The multi-faceted collaboration, announced on May 1 this year, aims to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.

The transaction builds on Quest Diagnostics’ leadership in oncology and subspecialized pathology services. It will support Pa...

>>> Read more: Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis